APPLICATIONS PUBLISHED 1 OCTOBER 2003
Published: 1-Mar-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Sustained release drug delivery devices with multiple agents
Bausch & Lomb 1347741*
Sustained release drug delivery devices with prefabricated permeable plugs
Bausch & Lomb 1347742*
Compsn for treatment of inflammatory disorders
Universiteit Utrecht Holding 1347743*
Solid dispersions of nitrate active principles
Nicox 1347744*
Dietary compsn containing conjugated linoleic acid and calcium for improved health
SmithKline Beecham 1347745*
Over-coated chewing gum formulations including tableted centre
WM Wrigley 1347746*
Method for preparing submicron particle suspensions
Baxter International 1347747*
Hydrostatic delivery system for controlled delivery of agent
MacGregor, Alexander 1347748*
Transdermal therapeutic system for controlled delivery of agent
LTS Lohmann Therapie-Systeme 1347749*
Treatment of male sexual dysfunction
Pfizer 1347750*
Methods of treating bone cancer and the pain associated therewith using endothelin antagonists
Abbott Laboratories 1347751*
Anti-proliferative drugs
Ramot at Tel-Aviv University 1347752*
Topical compsn and method for treating urinary stress incontinence
Medicare Management Consultancy 1347753*
Compsn for adhesion prevention
Daimond, Michael 1347754*
Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
Merck 1347755*
Controlled release of anti-arrhythmic agents from a biogradable polyethylene oxide hydrogel
Genzyme; Focal 1347756*
Method for detoxifying a carbohydrate containing solution
Gambro Lundia 1347757*
Azole compounds as anti-fungal agents
Ranbaxy Laboratories 1347758*
Antibacterial compounds
SmithKline Beecham 1347759*
NMDA receptor agonists pharmaceutical compsns
Pfizer Products 1347760*
Pharmaceutical formulation containing thienopyrimidines and antithrombitics, calcium antagonists, prostaglandins or prostaglandin derivatives
Merck Patent 1347761*
Pharmaceutical formulation containing thienopyrimidines and antithrombitics, calcium antagonists, prostaglandin derivatives (2)
Merck Patent 1347762*
Neuroactive steroid derivatives and methods of use
Trustees of Boston University 1347763*
Gel compsn and trans-scrotal application of a compsn for the treatment of hypergonadism
Dr August Wolff Chemisch-Pharmazeutische Fabrik 1347764*
Dermatological formulations
Kanford BV; Access Pharmaceuticals 1347765*
Compsn for the treatment of osteoarthritis
NV Neutrica 1347766*
Tahitian noni juice on Cox-1 and Cox-2 and Tahitian noni juice as a selective Cox-2 inhibitor
Morinda 1347767*
Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant Argania spinosa
Cognis France 1347768*
Cancer preventative effect of Morinda citrifolia
Morinda 1347769*
Method of making a protein polymer and uses of the polymer
Diversa 1347770*
Methods of using IMXP-888 and IMXP-888 antagonists
Immunex Corp 1347771*
Educated NK T-cells and their uses in the treatment of immune-related disorders
Hadasit Medical Research Services and Development 1347772*
Compsns and methods for enhancing cytokine activity and treating hypertension associated with the administration of cytokines
Metaphore Pharmaceuticals 1347773*
Modulation of cell growth by inhibiting binding of Kringle 2 domain of plasminogen
Isis Innovation 1347774*
Uses for polycationic compounds and vaccine adjuvants
Intercell 1347775*
Anti-inflammatory use of polycationic compounds
Intercell Biomedizinische Forschungs- and Entwicklungs; Cisterm Biotechnologies 1347776*
Immunogenic complex comprising ribosomes
Timmerman, Benedikt 1347777*
Behaviour chemotherapy
Be Able 1347778*
Use of a triple combination comprising a 5HT3 antagonist, a 5HT4 agonist and a laxative for promoting intestinal lavage
Janssen Pharmaceutica 1347779*
Compsns of N-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulphonamide and cyclic oligosaccharides
Pliva, Farmaceutska, Industrija 1347780*
Oral pharmaceutical compsns containing cyclodextrins as taste masking agent
Elan Corp 1347781*
Compsns comprising cyclodextrins and no-releasing drugs
Nicox 1347782*
Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units
Bayer 1347783*
Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
Bristol-Myers Squibb Pharma 1347784*
Method for conserving biological protheses, conserved biological protheses and conserving solutions
Frey, Rainer; Wachauf, Gerhard 1347785*
